Osteonecrosis of the femoral head (ONFH) is one of the most common orthopaedic diseases. The exact pathogenic mechanism of ONFH is still unknown. MicroRNAs 
| INTRODUCTION
Osteonecrosis of the femoral head (ONFH) is a refractory orthopaedic disease with progressive osteocyte and bone marrow necrosis as a result of interruption of blood supply to the femoral head, causing the associated structural changes and even collapse.
1-5 ONFH can be categorized as traumatic and non-traumatic. 6, 7 While the former occurs following physical trauma, the aetiology of non-traumatic ONFH is complicated and multifactorial. 8, 9 Alcohol addiction, preexisting abnormal circulating function and glucocorticoid treatment all increase the risk of non-traumatic ONFH. 1, 10, 11 ONFH is a devastating and progressive disease, which, if left untreated, will cause the collapse of the femoral head. 12, 13 Consequently, approximately 70% of patients need hip replacement. 14- 16 While existing theories have pointed to the roles of intravascular coagulation and fat embolism as well as extravascular fat accumulation-mediated vascular constriction in the pathogenesis of ONFH, 17 the exact mechanism is still largely unknown.
MicroRNAs (miRNAs) are a group of small, single-stranded, endogenous non-coding RNAs that negatively modulate expression of target mRNAs through binding to their 3′-untranslated region (3′-UTR)
to regulate their translation and/or stability. [18] [19] [20] [21] Previous studies have indicated that miRNAs play crucial roles in diverse physiological processes, including development, cell proliferation, differentiation, metabolism, migration and apoptosis. [22] [23] [24] [25] Increasing evidence also suggested that miRNAs can regulate bone development and regeneration and are directly involved in the pathogenesis of numerous of orthopaedic conditions, such as intervertebral disc degeneration, osteoarthritis, osteoporosis and osteosarcoma. [26] [27] [28] [29] Importantly, the roles of microRNAs in many of these orthopaedic conditions have been critically assessed. [30] [31] [32] Recently, several studies suggested that miRNAs play important roles in the development of ONFH. [33] [34] [35] Nevertheless, an in-depth appraisal of the related literature is still lacking.
In this review, we summarize dysregulated miRNAs and their pathogenic roles in ONFH. Furthermore, we discuss the potential applications of miRNAs as diagnostic markers and druggable targets in ONFH. and miR-146b-5p) were validated by using qRT-PCR. Taken together, these two studies suggested that miRNA expression in non-traumatic ONFH and femoral neck fracture were significantly different.
| DYSREGULATED MICRORNAS IDENTIFIED BY GENOME-WIDE APPROACHES IN ONFH

| Human ONFH tissues
| Mesenchymal stem cells
The use of glucocorticoids accounts for the majority of non- Through bioinformatic analysis, the upregulation of miR-21-3p and miR-652-5p and downregulation of miR-34b-3p, miR-34c-5p, miR148a-3p, miR-196a-5p, and miR-206-3p were predicted to be involved in osteogenic differentiation. These findings indicated that glucocorticosteroids could result in miRNA expression profile alterations in both human and murine mesenchymal stem cells. 
| CIRCULATING MICRORNAS AS DIAGNOSTIC MARKERS FOR ONFH
| MICRORNAS OF FUNCTIONAL SIGNIFICANCE IN ONFH
| miR-708
The imbalance between osteogenic and adipogenic differentiation in mesenchymal stem cells plays a crucial role in the pathogenesis of steroid-induced ONFH. [45] [46] [47] Hao et al 33 found that the expression of miR-708 was significantly upregulated in glucocorticoid-treated and ONFH patients' mesenchymal stem cells. In addition, they found that Smad3 (small mothers against decapentaplegic 3) was a direct target of miR-708. Targeting miR-708 enhanced the osteogenic differentiation and inhibited adipogenesis differentiation capability of mesenchymal stem cells. Knockdown of miR-708 also rescued the suppressive effect of glucocorticoid on osteonecrosis. 33 These data suggested that glucocorticoid might result in miR-708 overexpression to mediate its ONFH-promoting effect. This miRNA may thus act as a new therapeutic target for the prevention and treatment of ONFH.
| miR-210
Damage of endothelial cells was suggested to be one of the underlying mechanisms of steroid-induced ONFH whereas angiogenesis is key to the repair process following both traumatic and non-traumatic ONFH. 48 Therefore, any changes in the migration, apoptosis, prolif- factor-α, were also upregulated. 34 These results indicated that miR-210 is highly expressed in ONFH and may modulate angiogenesis in ONFH.
| miR-548d-5p
Sun et al 50 demonstrated that miR-548d-5p was downregulated dur- 
| miR-17-5p
Jia et al 51 reported that miR-17-5p expression level was lower in mesenchymal stem cells derived from non-traumatic ONFH patients 
| miR-27a
Through miRNA microarray, Gu et al 35 found that miR-27a expression was significantly downregulated in a rat model of steroid-induced ONFH. Besides, PPARγ and gremlin 1 (GREM1), both of which are direct targets of miRNA-27a, were significantly upregulated.
Functionally, downregulation of miR-27a promoted adipogenic differentiation whereas enforced expression of miR-27a suppressed adipogenesis and increased osteogenesis in the steroid-treated rat bone marrow mesenchymal stem cells. Knockdown of PPARγ and GREM1
also enhanced the osteogenic effect of miR-27a. These results suggested that miR-27a suppressed adipogenesis and enhanced osteogenesis through regulating GREM1 and PPARγ expression. Delivery of exogenous miR-27a might therefore be a novel therapeutic strategy in ONFH (Table 2) .
| CONCLUSIONS AND FUTURE PERSPECTIVE
Osteonecrosis of the femoral head is a progressive disease with disabling outcomes. 14 However, its unclear pathogenesis has hindered Smad: small mothers against decapentaplegic; PPARγ: peroxisome proliferator-activated receptors γ; GREM1: gremlin 1.
F I G U R E 1 Functional role of specific miRNAs in osteonecrosis of the femoral head the development of mechanism-driven treatment and prevention strategies. 53, 54 miRNAs were found to play crucial pathogenic roles in ONFH, 33, 34 especially through interacting with transcription factors involved in adipogenesis, osteogenesis and angiogenesis ( Figure 1 ). An increasing number of studies have also hinted at their potential therapeutic roles in ONFH. Nevertheless, one of the major unresolved issues is that osteonecrosis tissues, which is consisted of trabecular bone, bone marrow, blood vessels and cartilage, extracted from patients were used for 
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